MSCT与MRI动态增强扫描对HCC与IHPCC的鉴别价值  

The value of of MSCT and dynamic contrast-enhanced MRI in differential diagnosis of HCC and IHPCC

作　　者：殷锐 殷慧康 耿承军 YIN Rui;YIN Hui-kang;GENG Cheng-jun(Department of Medical Imaging,904 Hospital of Joint Logistics Support Force,Wuxi 214000,China)

机构地区：[1]联勤保障部队第904医院医学影像科,无锡214000

出　　处：《肝脏》2023年第1期83-85,99,共4页Chinese Hepatology

基　　金：江苏省自然科学基金面上项目(No:BK20201139)。

摘　　要：目的 探讨多层螺旋CT(MSCT)与MRI动态增强扫描对HCC与肝内周围型胆管细胞癌(IHPCC)的鉴别价值。方法 纳入76例原发性肝癌患者,均行MSCT与MRI动态增强扫描检查。结果 经病理检查,76例原发性肝癌患者中,共有52例HCC,24例IHPCC。HCC患者MSCT诊断结果符合率为84.62%(44/52),IHPCC患者MSCT诊断结果符合率为54.17%(13/24),总符合率为75.00%(57/76);HCC患者MRI诊断符合率为92.31%(48/52),IHPCC患者MRI诊断符合率为66.67%(16/24),总符合率为84.21%(64/76);MSCT联合MRI诊断,Kappa=0.882,P<0.05,联合诊断准确率为96.05%(73/76)。结论 MSCT、MRI均可用于HCC与IHPCC患者鉴别诊断,二者联合诊断效果更佳。Objective To explore the value of MSCT and dynamic contrast enhanced(DCE)-MRI in differential diagnosis of patients with hepatocellular carcinoma(HCC) and intrahepatic peripheral cholangiocarcinoma(IHPCC). Methods 76 patients with primary liver cancer was selected, both MSCT and DCE-MRI were performed. Results From the study group of 76 patients, 48 patients had HCC and 28 had IHPCC according to histopathological examination. The basic information of HCC patients and IHPCC patients were comparable(P>0.05). The diagnostic coincidence rate of MSCT of 44 cases with HCC was 84.62%(44/52), the diagnostic coincidence rate of MSCT of 13 cases with IHPCC was 54.17%(13/24), and the overall diagnostic coincidence rate was 75.00%(57/76). The diagnostic coincidence rate of MRI of 48 cases with HCC was 92.31%(48/52), the diagnostic coincidence rate of MRI of 16 cases with IHPCC was 66.67%(16/24), and the overall diagnostic coincidence rate was 84.21%(64/76). The results of MSCT combined with MRI, Kappa=0.882, P<0.05, and the combined diagnostic accuracy was 96.05%(73/76). Conclusion Both MSCT and MRI can be used for the differential diagnosis of HCC and IHPCC patients, and the two combined performs better in diagnosis.

关 键 词：MSCT MRI动态增强扫描 肝细胞癌 肝内周围型胆管细胞癌 

分 类 号：R735.7[医药卫生—肿瘤]